The epidemiology, etiology, and future prophylactic options for cancers in Mainland China
Mainland China accounts for 18.66% of the world’s population, 24.17% of global cancer new cases, and 26.44% cancer-related death worldwide in 2022. We aim to characterize the spatiotemporal distribution patterns of cancer burden, elucidate the main causes of high cancer burden, and propose evidence-...
Saved in:
| Main Authors: | Hongsen Chen, Jie Xu, Wenbin Liu, Xi Chen, Ping Li, Guangwen Cao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1579378/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer Burden in Chinese Older Adults: Insights Into Incidence, Mortality, and Global Comparisons Using GLOBOCAN 2022
by: Yuanjie Zheng, et al.
Published: (2025-06-01) -
Epidemiological characteristics and precise prophylaxis and control of primary liver cancer in China
by: CAO Guangwen
Published: (2024-11-01) -
Epidemiological trends of hepatitis in mainland China: 2004–2019
by: Si Chen, et al.
Published: (2025-08-01) -
Global trends and epidemiological shifts in gastrointestinal cancers: insights from the past four decades
by: Mengmeng Li, et al.
Published: (2025-07-01) -
Epidemiological trends of hepatitis C incidence and death in Mainland China between 2004 and 2018 and its predictions to 2030
by: Guo Tian, et al.
Published: (2025-04-01)